Profil
Chris Liang is the founder of Xcovery Holding, Inc., Tyrogenex, Inc. He previously worked as a Principal at Sugen, Inc.
Postes actifs de Chris Liang
| Sociétés | Poste | Début |
|---|---|---|
Xcovery Holding, Inc.
 Xcovery Holding, Inc. Miscellaneous Commercial ServicesCommercial Services Xcovery Holding, Inc. is a biopharmaceutical company based in Palm Beach Gardens, FL. Xcovery is focused on discovering medicines to fight advanced tumors and is developing a pipeline of oncology therapies to target a wide range of advanced tumors. The private company was founded by Chris Liang and has been led by CEO Giovanni Selvaggi since 2021. | Fondateur | - |
Anciens postes connus de Chris Liang
| Sociétés | Poste | Fin |
|---|---|---|
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Corporate Officer/Principal | - |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Health Technology |
Xcovery Holding, Inc.
Xcovery Holding, Inc. Miscellaneous Commercial ServicesCommercial Services Xcovery Holding, Inc. is a biopharmaceutical company based in Palm Beach Gardens, FL. Xcovery is focused on discovering medicines to fight advanced tumors and is developing a pipeline of oncology therapies to target a wide range of advanced tumors. The private company was founded by Chris Liang and has been led by CEO Giovanni Selvaggi since 2021. | Commercial Services |